QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-assumes-dyadic-international-at-buy-announces-price-target-of-3

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Dyadic International (NASDAQ:DYAI) with a Buy rating and anno...

 correction-dyadic-international-q2-eps-006-inline-sales-966630k-beat-600000k-estimate

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. Thi...

 dyadic-international-prices--575m-public-offering-of-6052m-shares-of-common-stock-at-095share

Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on...

 dyadic-international-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed

Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on...

 dyadic-international-announces-coo-joe-hazelton-appointed-as-president-effective-immediately

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team...

 dyadic-international-fy-2024-gaap-eps-020-beats-023-estimate-sales-350m-miss-430m-estimate

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION